Filtros : "Indexado no Cambridge Scientific Abstracts (CSA/CIG)" "International Journal of Cancer" Removido: "Franco, Alexandre" Limpar

Filtros



Refine with date range


  • Source: International Journal of Cancer. Unidade: FM

    Subjects: EMBOLIZAÇÃO TERAPÊUTICA, ONCOGENES, METÁSTASE NEOPLÁSICA, NEOPLASIAS

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MURAS, Angelita G. et al. Prion protein ablation increases cellular aggregation and embolization contributing to mechanisms of metastasis. International Journal of Cancer, v. 125, n. 7, p. 1523-1531, 2009Tradução . . Disponível em: https://doi.org/10.1002/ijc.24425. Acesso em: 17 nov. 2024.
    • APA

      Muras, A. G., Hajj, G. N. M., Ribeiro, K. B., Nomizo, R., Nonogaki, S., Chammas, R., & Martins, V. R. (2009). Prion protein ablation increases cellular aggregation and embolization contributing to mechanisms of metastasis. International Journal of Cancer, 125( 7), 1523-1531. doi:10.1002/ijc.24425
    • NLM

      Muras AG, Hajj GNM, Ribeiro KB, Nomizo R, Nonogaki S, Chammas R, Martins VR. Prion protein ablation increases cellular aggregation and embolization contributing to mechanisms of metastasis [Internet]. International Journal of Cancer. 2009 ; 125( 7): 1523-1531.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1002/ijc.24425
    • Vancouver

      Muras AG, Hajj GNM, Ribeiro KB, Nomizo R, Nonogaki S, Chammas R, Martins VR. Prion protein ablation increases cellular aggregation and embolization contributing to mechanisms of metastasis [Internet]. International Journal of Cancer. 2009 ; 125( 7): 1523-1531.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1002/ijc.24425
  • Source: International Journal of Cancer. Unidade: FCF

    Subjects: CARCINOGÊNESE ANIMAL, ANTINEOPLÁSICOS

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      KUROIWA-TRZMIELINA, Joice et al. Chemoprevention of rat hepatocarcinogenesis with histone deacetylase inhibitors: efficacy of tributyrin, a butyric acid prodrug. International Journal of Cancer, v. 124, n. 11, p. 2520-2527, 2009Tradução . . Disponível em: https://doi.org/10.1002/ijc.24212. Acesso em: 17 nov. 2024.
    • APA

      Kuroiwa-Trzmielina, J., Conti, A. de, Scolastici, C., Pereira, D., Horst, M. A., Purgatto, E., et al. (2009). Chemoprevention of rat hepatocarcinogenesis with histone deacetylase inhibitors: efficacy of tributyrin, a butyric acid prodrug. International Journal of Cancer, 124( 11), 2520-2527. doi:10.1002/ijc.24212
    • NLM

      Kuroiwa-Trzmielina J, Conti A de, Scolastici C, Pereira D, Horst MA, Purgatto E, Ong TP, Moreno FS. Chemoprevention of rat hepatocarcinogenesis with histone deacetylase inhibitors: efficacy of tributyrin, a butyric acid prodrug [Internet]. International Journal of Cancer. 2009 ; 124( 11): 2520-2527.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1002/ijc.24212
    • Vancouver

      Kuroiwa-Trzmielina J, Conti A de, Scolastici C, Pereira D, Horst MA, Purgatto E, Ong TP, Moreno FS. Chemoprevention of rat hepatocarcinogenesis with histone deacetylase inhibitors: efficacy of tributyrin, a butyric acid prodrug [Internet]. International Journal of Cancer. 2009 ; 124( 11): 2520-2527.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1002/ijc.24212

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024